UPDATE: Morgan Stanley Upgrades Acceleron Pharma (XLRN) to Overweight
Tweet Send to a Friend
(Updated - February 3, 2020 6:37 AM EST)
(updating comment)Morgan Stanley analyst Jeffrey Hung upgraded Acceleron Pharma (NASDAQ: XLRN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Morgan Stanley analyst Jeffrey Hung upgraded Acceleron Pharma (NASDAQ: XLRN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
